 | | DRUG: Doxazosin mesylate | |
| Entry |
|
|---|
| Name |
Doxazosin mesylate (USP);
Doxazosin mesilate (JP18);
Cardura (TN) |
|---|
| Product |
|
|---|
| Generic |
DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (A-S Medication Solutions), DOXAZOSIN (Accord Healthcare), DOXAZOSIN (American Health Packaging), DOXAZOSIN (Aphena Pharma Solutions - Tennessee), DOXAZOSIN (Aphena Pharma Solutions - Tennessee), DOXAZOSIN (Aphena Pharma Solutions - Tennessee), DOXAZOSIN (Aphena Pharma Solutions - Tennessee), DOXAZOSIN (Aphena Pharma Solutions - Tennessee), DOXAZOSIN (Apotex Corp.), DOXAZOSIN (Aurobindo Pharma Limited), DOXAZOSIN (AvKARE), DOXAZOSIN (AvPAK), DOXAZOSIN (Bryant Ranch Prepack), DOXAZOSIN (Bryant Ranch Prepack), DOXAZOSIN (Bryant Ranch Prepack), DOXAZOSIN (Bryant Ranch Prepack), DOXAZOSIN (Cardinal Health 107), DOXAZOSIN (Denton Pharma), DOXAZOSIN (Greenstone LLC), DOXAZOSIN (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals), DOXAZOSIN (Major Pharmaceuticals), DOXAZOSIN (Northwind Pharmaceuticals), DOXAZOSIN (Northwind Pharmaceuticals), DOXAZOSIN (Northwind Pharmaceuticals), DOXAZOSIN (Northwind Pharmaceuticals), DOXAZOSIN (NuCare Pharmaceuticals), DOXAZOSIN (NuCare Pharmaceuticals), DOXAZOSIN (PD-Rx Pharmaceuticals), DOXAZOSIN (Proficient Rx LP), DOXAZOSIN (REMEDYREPACK), DOXAZOSIN (REMEDYREPACK), DOXAZOSIN (REMEDYREPACK), DOXAZOSIN (REMEDYREPACK), DOXAZOSIN (REMEDYREPACK), DOXAZOSIN (Teva Pharmaceuticals USA), DOXAZOSIN (Upsher-Smith laboratories), DOXAZOSIN (Zydus Lifesciences Limited), DOXAZOSIN (Zydus Pharmaceuticals USA), DOXAZOSIN (direct rx), DOXAZOSIN MESYLATE (Aphena Pharma Solutions - Tennessee), DOXAZOSIN MESYLATE (Chartwell RX), DOXAZOSIN MESYLATE (Unichem Pharmaceuticals (USA)) |
|---|
| Formula |
C23H25N5O5. CH4SO3
|
|---|
| Exact mass |
547.1737
|
|---|
| Mol weight |
547.5808
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01465 alpha-Adrenergic receptor antagonist
DG01457 alpha1-Adrenergic receptor antagonist
DG01739 Peripherally-acting antiadrenergic
DG03231 Antihypertensive
|
|---|
| Remark |
| Therapeutic category: | 2149 |
| Product (DG00256): | D00608<JP/US> |
|
|---|
| Efficacy |
Antihypertensive, alpha1-Adrenergic receptor antagonist |
|---|
| Disease |
|
|---|
| Comment |
Prazosin derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07215 | alpha-Adrenergic receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02CA Alpha-adrenoreceptor antagonists
C02CA04 Doxazosin
D00608 Doxazosin mesylate (USP) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Alpha-adrenergic Blocking Agents
Doxazosin
D00608 Doxazosin mesylate (USP)
Genitourinary Agents
Benign Prostatic Hypertrophy Agents
Doxazosin
D00608 Doxazosin mesylate (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D00608 Doxazosin mesylate (USP); Doxazosin mesilate (JP18)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01465 alpha-Adrenergic receptor antagonist
DG01457 alpha1-Adrenergic receptor antagonist
DG00256 Doxazosin
D00608 Doxazosin mesylate
DG01739 Peripherally-acting antiadrenergic
DG00256 Doxazosin
D00608 Doxazosin mesylate
DG03231 Antihypertensive
DG00256 Doxazosin
D00608 Doxazosin mesylate
Drug classes [BR:br08332]
Cardiovascular agent
DG03231 Antihypertensive
D00608 Doxazosin mesylate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D00608 Doxazosin mesylate (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00608 Doxazosin mesilate
D00608 Doxazosin mesilate tablets
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01465 alpha-Adrenergic receptor antagonist
DG01457 alpha1-Adrenergic receptor antagonist
DG00256 Doxazosin
DG01739 Peripherally-acting antiadrenergic
DG00256 Doxazosin
DG03231 Antihypertensive
DG00256 Doxazosin
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 38
1 C8y C 31.6040 -15.7396
2 C8y C 31.5972 -17.1405
3 N5x N 30.3332 -15.0390
4 C8x C 32.7548 -15.0458
5 C8x C 32.7415 -17.8476
6 C8y C 30.3131 -17.8410
7 C8y C 29.1124 -15.7328
8 C8y C 33.9624 -15.7529
9 C8y C 33.9556 -17.1539
10 N5x N 29.1057 -17.1339
11 N1a N 30.3131 -19.2419
12 N1y N 27.8983 -15.0325
13 O2a O 35.1764 -15.0592
14 O2a O 35.1698 -17.8609
15 C1x C 26.6841 -15.7195
16 C1x C 27.9049 -13.6249
17 C1a C 36.3905 -15.7663
18 C1a C 36.3839 -17.1672
19 C1x C 25.4765 -15.0191
20 C1x C 26.6974 -12.9243
21 N1y N 25.4899 -13.6249
22 C5a C 24.2756 -12.9177
23 C1y C 23.0549 -13.6115
24 O5a O 24.2824 -11.5167
25 O2x O 21.8407 -12.9044
26 C1x C 23.0484 -15.0123
27 C8y C 20.6266 -13.6047
28 O2x O 21.8341 -15.7061
29 C8y C 20.6200 -15.0058
30 C8x C 19.4191 -12.8976
31 C8x C 19.4191 -15.6995
32 C8x C 18.1984 -13.6047
33 C8x C 18.1984 -15.0058
34 S4a S 22.5632 -18.8794
35 C1a C 21.1692 -18.8727
36 O1d O 23.9576 -18.8794
37 O1d O 22.5567 -17.4851
38 O1d O 22.5567 -20.2737
BOND 41
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 3 7 1
7 4 8 2
8 5 9 2
9 6 10 1
10 6 11 1
11 7 12 1
12 8 13 1
13 9 14 1
14 12 15 1
15 12 16 1
16 13 17 1
17 14 18 1
18 15 19 1
19 16 20 1
20 19 21 1
21 21 22 1
22 22 23 1
23 22 24 2
24 23 25 1
25 23 26 1
26 25 27 1
27 26 28 1
28 27 29 1
29 27 30 2
30 29 31 2
31 30 32 1
32 31 33 1
33 7 10 2
34 8 9 1
35 20 21 1
36 28 29 1
37 32 33 2
38 34 35 1
39 34 36 1
40 34 37 2
41 34 38 2
|
|---|
|
» Japanese version » Back
|
|